Zobrazeno 1 - 10
of 43
pro vyhledávání: '"ampiroxicam"'
Autor:
Pengfei Zhao, Ying Qi
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Ampiroxicam is a long-acting, non-steroidal anti-inflammatory drug that selectively inhibits human cyclooxygenase, effectively mitigating fever, pain, and inflammation. This study evaluated the drug's tolerability and pharmacokinetics t
Externí odkaz:
https://doaj.org/article/7a8cac492d4d4733ba58141fa34452b1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Chemistry of Heterocyclic Compounds. 49:39-65
Many compounds bearing a sulfonamide fragment have been used in medicinal practice for a long time, e.g., as antibacterial or hypoglycaemic agents [1, 2]. However, the interest in sulfonamides as potential medications has not decreased until now [3].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e528a7bb6a314db0dffc7d2df9106fd1
https://doi.org/10.1007/s10593-013-1231-3
https://doi.org/10.1007/s10593-013-1231-3
Publikováno v:
奥羽大学歯学誌. (2号):35
特に歯科領域の薬物療法の中心である鎮痛消炎薬・消炎酵素薬及び抗菌薬について、平成16年度から19年度までの使用動向の調査を行った。内服の鎮痛消炎薬・消炎酵素薬12種22品目、内
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::5815734e4ade6d0d423a90354c3ee3ae
https://ohu-lib.repo.nii.ac.jp/records/3447
https://ohu-lib.repo.nii.ac.jp/records/3447
Autor:
Vivekkumar K. Redasani, Sanjay B. Bari
Prodrugs play a central role in drug discovery and designing. There are so many therapeutic areas where this approach can be utilized. This is going to be an emerging approach in years to come. Now-a-days large numbers of drugs are derivatizing into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f3960bcd6660017b54bd9fa3c827a6
https://doi.org/10.1016/b978-0-12-803519-1.00006-4
https://doi.org/10.1016/b978-0-12-803519-1.00006-4
Autor:
Kohei Funasaka, Yoshiki Hirooka, Takafumi Ando, R. Miyahara, Makoto Ishihara, Osamu Watanabe, Naoki Ohmiya, Eizaburo Ohno, Hiroki Kawashima, Masanao Nakamura, Hidemi Goto, Akihiro Itoh
Publikováno v:
Alimentary Pharmacology & Therapeutics.
Summary Background The aetiology for nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injuries has not been well characterised. Aim To determine the risk factors of symptomatic NSAID-induced small intestinal injuries, including di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c73f1b2bada8af5bc503dcdc7ee945d
https://doi.org/10.1111/apt.12858
https://doi.org/10.1111/apt.12858
Autor:
Hisanori Shimizu, Hirohiko Sueki, Toshinori Yamamoto, Inketsu Soh, Yukio Kuroiwa, Masafumi Iijima, Takeshi Hariya, Tadanori Sasaki, Shogo Tokuyama
Publikováno v:
Journal of Dermatological Science. 21:170-175
Ampiroxicam (APX), a prodrug of piroxicam (PXM), has been reported to induce photosensitivity. Antigenic characterization of these photosensitivities, however, is still insufficient. The purpose of the present study was to elucidate further mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c2d4f870c2aab4f4c8b7ad9a70631d8
https://doi.org/10.1016/s0923-1811(99)00036-5
https://doi.org/10.1016/s0923-1811(99)00036-5
Autor:
Satoshi Uno, Tadatoshi Tanino, Hiroaki Tanaka, Eri Kobayashi, Masahiro Iwaki, Taro Ogiso, Arisa Sawada
Publikováno v:
Biological and Pharmaceutical Bulletin. 22:191-196
The aim of the present study was to determine the effect of sulfaphenazole (SP) on the pharmacokinetics of ampiroxicam (AM) which is metabolized by cytochrome P-450 (CYP) 2C9, since SP is a potent inhibitor of CYP 2C9, and so a dramatic pharmacokinet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a3942c3f48fba0e47dc675b1f78113
https://doi.org/10.1248/bpb.22.191
https://doi.org/10.1248/bpb.22.191
Publikováno v:
ChemInform. 44
Many compounds bearing a sulfonamide fragment have been used in medicinal practice for a long time, e.g., as antibacterial or hypoglycaemic agents [1, 2]. However, the interest in sulfonamides as potential medications has not decreased until now [3].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cc826860fa87dec630d6a713eb9a3e7
https://doi.org/10.1002/chin.201335216
https://doi.org/10.1002/chin.201335216
Autor:
Tomoko Okuno, Toru Endo, Jingorou Shimada, Yoichirou Kawakami, Toshitaka Kudo, Yuko Murayama, Akira Yanagawa, Takemasa Nakagawa, Masakatsu Nomura, Koji Kusakari
Publikováno v:
Ensho. 16:363-367
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a069667d300517401067223417dacf0a
https://doi.org/10.2492/jsir1981.16.363
https://doi.org/10.2492/jsir1981.16.363